NCT03433963View on ClinicalTrials.gov

The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

July 4, 2019

Study Completion Date

March 31, 2020

Conditions
Blood PressureCardiac Ischemia
Interventions
DIETARY_SUPPLEMENT

L-Arg supplement

L-Arg supplement will be prepared as pills, administered 9g each day in 3 times for 2 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo will be prepared as pills (the same size, color and shape as of L-Arg), administered 3 times daily for 2 weeks.

Trial Locations (3)

100091

Qinglongqiao Community Health Service Center, Beijing

100191

Malianwa Community Health Service Center, Beijing

Shangdi Community Health Service Center, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT03433963 - The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution | Biotech Hunter | Biotech Hunter